Skip to content

Ginkgo Bioworks

US · DNA #3438 by market cap
11.47 -0.94 -7.57%
Live - 5344 symbols - heartbeat 291s ago · 2026-10-08 09:20
Pre-market 10.92 -4.80%
After-hours 11.31 -1.40%
Overnight 11.46 -0.09%
Market cap
772.39M
P/B
1.84
EPS
-5.64
Reader sentiment Are you bullish or bearish on DNA?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 7.0 percentage points.

Institutional ownership

Held by institutions
59.06% -6.99pp
Institutions
216 -3
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund35.57%
Individual/Insider14.96%
Hedge Fund13.85%
Family Office/Trust4.95%
Public Company2.29%
VC/PE Fund1.13%
Private Company0.79%
Insurance Company0.31%
Government Pension Fund0.17%
Other25.98%

Top holders as of 2026-06-30

BlackRock 6.36% · 4.28M sh
Viking Global Investors LP 5.31% · 3.58M sh
Cascade Investment, L.L.C. 4.93% · 3.32M sh
Erste Asset Management GmbH 3.77% · 2.54M sh
Reshma Shetty 3.69% · 2.49M sh
Vanguard Capital Management, LLC 3.56% · 2.40M sh
Baillie Gifford 3.55% · 2.39M sh
Austin Che 3.54% · 2.39M sh
Bartholomew Canton 3.54% · 2.38M sh
Jason Kelly 3.50% · 2.36M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 18 buys · 32 sells

NameRoleStake
Reshma Shetty Founder, President, COO & Director 3.69%
Austin Che Founder, Head of Strategy & Treasurer 3.54%
Bartholomew Canton Founder, CTO & Secretary 3.54%
Jason Kelly Chief Executive Officer 3.50%
Harry Sloan Independent Director 0.40%
Shyam Sankar Independent Chairperson 0.11%
Steven Coen Chief Accounting Officer 0.08%
Sriram Kosuri Director 0.04%
Christian O. Henry Independent Director 0.03%
Ross Fubini Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-04 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -2,403 $15.00
2026-09-16 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $7.29
2026-09-14 Christian O. Henry Independent Director Open Market Disposition -5,000 $7.08
2026-08-23 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -330 $6.98
2026-08-23 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -330 $6.98
2026-08-20 Steven Coen Chief Accounting Officer Derivative Exercise and Retained +413 --
2026-08-16 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $6.66
2026-07-27 Jason Kelly Chief Executive Officer Other Derivative Acquisition +383,725 --
2026-07-27 Reshma Shetty Founder, President, COO & Director Other Derivative Acquisition +319,332 --
2026-07-27 Bartholomew Canton Founder, CTO & Secretary Other Derivative Acquisition +319,332 --
2026-07-16 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -752 $7.90
2026-07-16 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -752 $7.90
2026-07-15 Steven Coen Chief Accounting Officer Derivative Exercise and Retained +734 --
2026-06-10 Harry Sloan Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Christian O. Henry Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Ross Fubini Independent Director Other Derivative Acquisition +25,000 --
2026-06-10 Sriram Kosuri Director Other Derivative Acquisition +25,000 --
2026-06-09 Austin Che Founder, Head of Strategy & Treasurer Intent to Sell (Form 144) -2,200 $8.06
2026-05-21 Steven Coen Chief Accounting Officer Derivative Exercise and Sale -307 $8.33
2026-05-21 Steven Coen Chief Accounting Officer Intent to Sell (Form 144) -307 $8.33

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 09:20:28 · For reference only, not investment advice and not tailored to your situation.